title: Predicting progression in glaucoma suspects with longitudinal estimates of retinal ganglion cell counts.
abstract: OBJECTIVE
  We evaluated the ability of baseline and longitudinal estimates of retinal ganglion cell (RGC) counts in predicting progression in eyes suspected of having glaucoma.
  
  
  METHODS
  The study included 288 glaucoma suspect eyes of 288 patients followed for an average of 3.8 ± 1.0 years. Participants had normal standard automated perimetry (SAP) at baseline. Retinal nerve fiber layer thickness assessment was performed with optical coherence tomography (OCT). Progression was defined as development of repeatable abnormal SAP or glaucomatous progressive optic disc changes. Estimates of RGC counts were obtained by combining data from SAP and OCT according to a previously described method. Joint longitudinal survival models were used to evaluate the ability of baseline and rates of change in estimated RGC counts for predicting progression over time, adjusting for confounding variables.
  
  
  RESULTS
  A total of 48 eyes (17%) showed progression during follow-up. The mean rate of change in estimated RGC counts was -18,987 cells/y in progressors versus -8,808 cells/y for nonprogressors (P < 0.001). Baseline RGC counts and slopes of RGC loss were significantly predictive of progression, with HRs of 1.56 per 100,000 cells lower (95% confidence interval [CI], 1.18-2.08; P = 0.002) and 2.68 per 10,000 cells/y faster loss (95% CI, 1.22-5.90; P = 0.014), respectively. The longitudinal model including estimates of RGC counts performed significantly better than models including only structural or functional indexes separately.
  
  
  CONCLUSIONS
  Baseline and longitudinal estimates of RGC counts may be helpful in predicting progression and performed significantly better than conventional approaches for risk stratification of glaucoma suspects.
authors: Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla, CA, USA.
authors: Daniel
authors: D
authors: Meira-Freitas
authors: Renato
authors: R
authors: Lisboa
authors: Andrew
authors: A
authors: Tatham
authors: Linda M
authors: LM
authors: Zangwill
authors: Robert N
authors: RN
authors: Weinreb
authors: Christopher A
authors: CA
authors: Girkin
authors: Jeffrey M
authors: JM
authors: Liebmann
authors: Felipe A
authors: FA
authors: Medeiros
mesh_terms: D000368:Aged; D002452:Cell Count / Q000379:methods; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012165:Retinal Ganglion Cells / Q000473:pathology*; D041623:Tomography, Optical Coherence
keywords: glaucoma; intraocular pressure; optic nerve head; optical coherence tomography; visual field
references: Ophthalmology. 2007 Jan;114(1):3-9
references: 17070596
references: Lancet. 2011 Apr 16;377(9774):1367-77
references: 21453963
references: Arch Ophthalmol. 2010 May;128(5):551-9
references: 20457975
references: Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2382-9
references: 22427577
references: Ophthalmology. 2009 Oct;116(10):1846-53
references: 19592110
references: J Glaucoma. 2006 Aug;15(4):299-305
references: 16865006
references: Ophthalmology. 2007 Jan;114(1):10-9
references: 17095090
references: Stat Med. 2012 Oct 15;31(23):2627-43
references: 21520455
references: Arch Ophthalmol. 2009 Sep;127(9):1136-45
references: 19752422
references: Arch Ophthalmol. 2009 Oct;127(10):1250-6
references: 19822839
references: Am J Ophthalmol. 1996 May;121(5):511-21
references: 8610794
references: Prog Retin Eye Res. 2010 Jul;29(4):249-71
references: 20226873
references: Br J Ophthalmol. 2009 Aug;93(8):1057-63
references: 19429591
references: Invest Ophthalmol Vis Sci. 1992 Jan;33(1):153-9
references: 1730536
references: J Glaucoma. 2014 Jan;23(1):1-4
references: 22668983
references: Am J Ophthalmol. 2002 Jan;133(1):19-28
references: 11755836
references: Invest Ophthalmol Vis Sci. 2012 Oct 05;53(11):6939-46
references: 22893677
references: Arch Ophthalmol. 2005 Oct;123(10):1351-60
references: 16219726
references: Am J Ophthalmol. 2012 Nov;154(5):814-824.e1
references: 22840484
references: Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5794-803
references: 21693614
references: Biostatistics. 2000 Dec;1(4):465-80
references: 12933568
references: Biometrics. 1997 Mar;53(1):330-9
references: 9147598
references: Ophthalmology. 2007 Dec;114(12):2232-7
references: 17980433
references: Eye (Lond). 2009 Aug;23(8):1647-52
references: 19011607
references: Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30
references: 12049575
references: Am J Ophthalmol. 2012 Jun;153(6):1197-205.e1
references: 22317914
references: Invest Ophthalmol Vis Sci. 2000 Mar;41(3):741-8
references: 10711689
references: Arch Ophthalmol. 2012 May;130(5):E1-10
references: 22826832
references: Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
references: 12049574
references: Arch Ophthalmol. 1999 May;117(5):573-83
references: 10326953
references: BMC Ophthalmol. 2011 Feb 11;11:6
references: 21314957
references: Ophthalmology. 2014 Jan;121(1):100-109
references: 23948465
references: Arch Ophthalmol. 2006 Jun;124(6):853-9
references: 16769839